Skip to Content

Join the 'von Willebrand's Disease' group to help and get support from people like you.

von Willebrand's Disease News

Is Blood Donated by Mothers Less Safe for Men?

Posted 17 Oct 2017 by Drugs.com

TUESDAY, Oct. 17, 2017 – Men who receive blood donated by previously pregnant women may face an increased risk of death following the transfusion, a new study from the Netherlands suggests. Males transfused with blood from a woman with a history of pregnancy appear to be 13 percent overall more likely to die in coming years, compared with those who received blood from another man, said ...

First Test to Detect Zika in Blood Donations Approved

Posted 7 Oct 2017 by Drugs.com

FRIDAY, Oct. 6, 2017 – The cobas Zika test has been approved by the U.S. Food and Drug Administration – the first approved screening test to detect the Zika virus in blood donations. The test is not designed to diagnose any particular person's Zika infection, however, the FDA said. In August 2016, the agency recommended that all U.S. states and territories screen blood for Zika, according to an ...

Health Tip: Giving Blood

Posted 4 Oct 2017 by Drugs.com

-- Donating blood for the first time may sound intimidating. But the process is fairly painless, takes only about 20 minutes and could help save a life. The American Red Cross explains the different types of blood donation: Whole blood – The most common and quickest type of donation, involving a pint of whole blood. The donation is typically separated into transfusable components, including red ...

Vonvendi Approved to Control Bleeding Disorder

Posted 12 Dec 2015 by Drugs.com

TUESDAY, Dec. 8, 2015 – Vonvendi has been approved to treat adults with von Willebrand disease (VWD), the most common inherited bleeding disorder. VWD, affecting about 1 percent of the U.S. population, is caused by lack of a protein that's essential for blood clotting. People with the disorder can develop severe bleeding from the nose, gums, intestines, muscles and joints. Women with VWD also ...

FDA Approves Vonvendi (Von Willebrand Factor (Recombinant)) to Treat Bleeding Episodes in Patients with VWD

Posted 10 Dec 2015 by Drugs.com

December 8, 2015 – The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with VWD. VWD is ...

Octapharma USA Announces FDA Approval of Wilate - the First Replacement Therapy Developed Specifically for von Willebrand Disease

Posted 9 Dec 2009 by Drugs.com

HOBOKEN, N.J., Dec. 7 /PRNewswire/ – Octapharma USA today announced the U.S. Food and Drug Administration has approved wilate for the treatment of spontaneous and trauma-induced bleeding episodes in patients with all types of von Willebrand disease (VWD). Wilate is a newly developed, high-purity, double virus inactivated von Willebrand Factor/Coagulation Factor VIII Concentrate (Human) that ...

Ask a Question

Further Information

Related Condition Support Groups

Coagulation Defects and Disorders

Related Drug Support Groups

desmopressin, DDAVP, von willebrand factor, Humate-P, Stimate, antihemophilic factor / von willebrand factor, Wilstart, Haemate P, Optivate, Alphanate, Wilfactin, Wilate, Vonvendi